乐天堂app下载

Professor Mark W Grinstaff is 乐天堂app下载 William Fairfield Warren Distinguished Professor, and Professor of Biomedical Engineering, Chemistry, Materials Science and Engineering, and Medicine at Boston University (BU). He is also 乐天堂app下载 Director of BU’s Nanotechnology Innovation Center and 乐天堂app下载 Director of 乐天堂app下载 NIH T32 Biomaterials Program ‘Translational Research in Biomaterials’.

Mark's awards include 乐天堂app下载 ACS Nobel Laureate Signature Award, NSF Career Award, Pew Scholar in 乐天堂app下载 Biomedical Sciences, Camille Dreyfus Teacher-Scholar, Alfred P Sloan Research Fellowship, 乐天堂app下载 Edward M Kennedy Award for Health Care Innovation, 乐天堂app下载 Clemson Award for Applied Research, and 乐天堂app下载 ACS Award in Applied Polymer Science. He is a Fellow of 乐天堂app下载 American Institute of Medical and Biological Engineering, 乐天堂app下载 American Academy of Nanomedicine, 乐天堂app下载 American Institute of Chemists, 乐天堂app下载 Biomedical Engineering Society, 乐天堂app下载 Royal Chemical Society, 乐天堂app下载 Royal Society of Medicine, 乐天堂app下载 International Academy of Medical and Biological Engineering, 乐天堂app下载 American Association for 乐天堂app下载 Advancement of Science, and a Founding Fellow of 乐天堂app下载 National Academy of Inventors.

Over 乐天堂app下载 course of his tenure, Mark’s ground-breaking research has yielded more than 400 peer-reviewed publications, more than 200 patents and patent applications, and more than 325 oral presentations. His work has been cited over 40,000 times. He is an entrepreneur and co-founder, and his innovative ideas have led to several new regulatory approved products that are now 乐天堂app下载 standard of care.

His current research activities involve 乐天堂app下载 syn乐天堂app下载sis of new macromolecules and biomaterials, self-assembly chemistry, imaging contrast agents, drug delivery, and wound repair.